Chimeric Antigen Receptor (CAR) T-cell Immunotherapy for Hepatocellular Carcinoma: A Review of Current Progress and Challenges. Int J Mod Med [Internet]. 2025 Jun. 16 [cited 2025 Sep. 12];4(06):1-7. Available from: http://www.intjmm.com/index.php/ijmm/article/view/64